Krϋppel-like factor 15 suppresses renal glomerular mesangial cell proliferation via enhancing P53 SUMO1 conjugation

Lingling Wu1, Ou Li1, Fengge Zhu1

  • 1Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases, Chinese PLA Institute of Nephrology, Chinese PLA General Hospital, Beijing, China.

Insights

Krüppel-like factor 15 (KLF15) targets small ubiquitin-related modifier 1 (SUMO1) to inhibit kidney mesangial cell proliferation by stabilizing P53. This pathway is crucial for understanding and treating renal diseases involving mesangial cell growth.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Mesangial cell (MC) proliferation is central to renal diseases like nephritis and diabetic nephropathies.
  • Understanding MC responses to pathological stimuli is vital for disease comprehension.
  • Krüppel-like factor 15 (KLF15) was previously identified as an inhibitor of MC proliferation.

Purpose of the Study:

  • To elucidate the direct target gene of KLF15.
  • To uncover the mechanism by which KLF15 regulates mesangial proliferation.
  • To investigate the role of KLF15-SUMO1 pathway in P53 stability and cell cycle regulation.

Main Methods:

  • Screening for KLF15 transcriptional targets.
  • Chromatin immunoprecipitation followed by PCR (ChIP-PCR) and luciferase assays for validation.
  • Overexpression and knockdown studies in human renal mesangial cells (HRMCs).
  • Assessment of P53 stability and SUMOylation.
  • Analysis of SUMOylated P53 levels in a rat model of nephritis.

Main Results:

  • Small ubiquitin-related modifier 1 (SUMO1) was identified as a direct transcriptional target of KLF15.
  • Overexpression of KLF15 or SUMO1 stabilized P53, inducing cell cycle arrest and inhibiting HRMC proliferation.
  • Knockdown of SUMO1 abrogated the anti-proliferative effects of KLF15 and reduced P53 SUMOylation.
  • SUMOylated P53 levels were decreased in kidney cortices during proliferative phases in an anti-Thy 1 nephritis model.

Conclusions:

  • KLF15 targets SUMO1 to regulate mesangial cell proliferation.
  • The KLF15-SUMO1-P53 axis is a critical mechanism controlling renal mesangial cell cycle.
  • This pathway offers potential therapeutic targets for renal diseases characterized by MC proliferation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K